PI
ENTA icon

PineBridge Investments’s Enanta Pharmaceuticals ENTA Stock Holding History

PineBridge Investments’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,837
Closed -$608K – 848
2019
Q4 		$608K Sell
9,837
-5,475
-36% -$339K 0.01% 817
2019
Q3 		$920K Buy
15,312
+1,277
+9% +$94.9K 0.01% 784
2019
Q2 		$1.18M Buy
14,035
+10,115
+258% +$910K 0.02% 602
2019
Q1 		$374K Buy
3,920
+67
+2% +$6.01K 0.01% 754
2018
Q4 		$273K Buy
3,853
+423
+12% +$32.4K 0.01% 806
2018
Q3 		$293K Buy
3,430
+954
+39% +$95.6K 0.01% 841
2018
Q2 		$287K Sell
2,476
-397
-14% -$39.6K 0.01% 809
2018
Q1 		$232K Buy
+2,873
New +$221K 0.01% 867
2017
Q4 		– Sell
-1,772
Closed -$82K – 1073
2017
Q3 		$82K Sell
1,772
-58
-3% -$2.33K ﹤0.01% 978
2017
Q2 		$66K Sell
1,830
-21,855
-92% -$699K ﹤0.01% 986
2017
Q1 		$729K Buy
23,685
+7,825
+49% +$244K 0.02% 586
2016
Q4 		$531K Buy
15,860
+14,093
+798% +$404K 0.02% 628
2016
Q3 		$47K Buy
1,767
+227
+15% +$5.27K ﹤0.01% 975
2016
Q2 		$34K Hold
1,540
– – ﹤0.01% 1012
2016
Q1 		$45K Sell
1,540
-218
-12% -$6.07K ﹤0.01% 938
2015
Q4 		$58K Buy
1,758
+275
+19% +$8.96K ﹤0.01% 909
2015
Q3 		$54K Buy
+1,483
New +$63.7K ﹤0.01% 912

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

PineBridge Investments's ENTA Position: Q1 2020 in Review

PineBridge Investments sold out of Enanta Pharmaceuticals (ENTA) in Q1 2020, closing a stake of 9,837 shares — an estimated $608K sold.

PineBridge Investments first reported a position in ENTA in Q3 2015 and held it in 17 quarters. The position peaked at $1.18M in Q2 2019. 156 funds tracked by Wall St. Rank hold ENTA as of Q1 2020.

  • PineBridge Investments reported no remaining Enanta Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • PineBridge Investments sold 9,837 Enanta Pharmaceuticals shares in Q1 2020, an estimated $608K.
  • PineBridge Investments first reported a position in Enanta Pharmaceuticals in Q3 2015 and held it in 17 quarters.
  • PineBridge Investments's Enanta Pharmaceuticals position peaked at $1.18M in Q2 2019.
  • 156 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2020.

Based on PineBridge Investments's 13F filing for Q1 2020, filed 14 May 2020.